drugset

drugset / Trial / NCT01187589

PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients

NCT01187589 ↗

Completed 15 enrolled Respinova LTD

RandomizedCrossoverTriple-blindTreatment

Summary

This study is aimed at finding the effect of PulseHaler™ with Albuterol on Lung Deposition of Aerosol and on Pulmonary Functions in COPD Patients

Timeline

Start: 2010-12
Primary completion: 2011-09
Completion: 2011-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Salbutamol	Unknown	0.5 ml	Inhaled

Indications